| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.06 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.097 | 0.07 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.06 | 0.08 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.08 |